(CLMT) Calumet Specialty Products - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1314761032
CLMT: Solvents, Waxes, Lubricating Oils, Renewable Fuels, Asphalt, Jet Fuel
Calumet Specialty Products Partners (NASDAQ:CLMT) is a diversified specialty products and renewable fuels company with a strong presence in North America and international markets. Since its founding in 1919, the company has built a reputation for delivering high-quality, customized solutions across various industrial and consumer-facing sectors.
Operating through three distinct segments—Specialty Products and Solutions, Montana/Renewables, and Performance Brands—Calumet offers a broad range of products. The Specialty Products and Solutions segment provides solvents, waxes, and customized lubricating oils, catering to industries requiring precise formulations. The Montana/Renewables segment is a key player in processing renewable feedstocks into bio-based products like renewable diesel and sustainable aviation fuel, alongside conventional refining of Canadian crude oil into fuels and asphalt. The Performance Brands segment, which includes Royal Purple, Bel-Ray, and TruFuel, focuses on high-performance lubricants and fuels for niche markets.
With a market capitalization of $1.422 billion, Calumet trades on the NASDAQ under the ticker symbol CLMT. The company’s financial metrics, including a forward P/E ratio of 11.35 and a price-to-book ratio of 19.32, provide insight into its valuation. Calumet’s diverse operations and strategic focus on renewable energy position it as a significant player in the evolving energy landscape, making it a notable consideration for investors and fund managers interested in the specialty chemicals and renewable fuels sectors.
Additional Sources for CLMT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLMT Stock Overview
Market Cap in USD | 1,422m |
Sector | Energy |
Industry | Oil & Gas E&P |
GiC Sub-Industry | Oil & Gas Refining & Marketing |
IPO / Inception | 2006-01-26 |
CLMT Stock Ratings
Growth 5y | 84.5% |
Fundamental | -57.2% |
Dividend | 13.9% |
Rel. Strength Industry | -15.7 |
Analysts | 4/5 |
Fair Price Momentum | 15.53 USD |
Fair Price DCF | - |
CLMT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 46.5% |
CLMT Growth Ratios
Growth Correlation 3m | -72.6% |
Growth Correlation 12m | 68.4% |
Growth Correlation 5y | 85.6% |
CAGR 5y | 30.92% |
CAGR/Mean DD 5y | 1.69 |
Sharpe Ratio 12m | 0.16 |
Alpha | -31.61 |
Beta | 1.14 |
Volatility | 85.97% |
Current Volume | 1211.7k |
Average Volume 20d | 1506.1k |
As of February 19, 2025, the stock is trading at USD 16.08 with a total of 1,211,688 shares traded.
Over the past week, the price has changed by +1.26%, over one month by +0.25%, over three months by -21.83% and over the past year by -6.24%.
No, based on ValueRay Fundamental Analyses, Calumet Specialty Products (NASDAQ:CLMT) is currently (February 2025) a stock to sell. It has a ValueRay Fundamental Rating of -57.18 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLMT as of February 2025 is 15.53. This means that CLMT is currently overvalued and has a potential downside of -3.42%.
Calumet Specialty Products has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CLMT.
- Strong Buy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CLMT Calumet Specialty Products will be worth about 17.9 in February 2026. The stock is currently trading at 16.08. This means that the stock has a potential upside of +11.32%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 25 | 55.5% |
Analysts Target Price | 24.6 | 53% |
ValueRay Target Price | 17.9 | 11.3% |